IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 11

Issue Published : 118

Article Submitted : 21664

Article Published : 8541

Total Authors : 22459

Total Reviewer : 811

Total Countries : 159

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Formulation Method Development And Validation Of Active Pharmaceutical Ingredient in Tablet Dosage Form
Authors Name: Pranjali Vilas Shandilya , S.G.Jawarkar
Download E-Certificate: Download
Author Reg. ID:
IJRTI_204990
Published Paper Id: IJRTI2506188
Published In: Volume 10 Issue 6, June-2025
DOI:
Abstract: Abstract: Rapid and accurate HPLC method has been developed for the simultaneous estimation of Meloxicam and Rizatriptan in tablet dosage form. Chromatographic separation of both anti-inflammatory drugs was achieved on a Zodiac-100 C18 (150 × 4.6 mm ID, 5 µm) using a mobile phase consisting of 760 mL methanol and 240 mL of buffer (0.2% ammonium acetate in water), at a flow rate of 1.0 mL/min. Detection was carried out at 245 nm. The separation was achieved in less than 10 minutes. The method was validated as per ICH guidelines for parameters including linearity, accuracy, precision, system suitability, specificity, robustness, limit of detection (LOD), limit of quantitation (LOQ), and range. Linearity, accuracy, and precision were found to be within acceptable limits over the range of 0.5–3.0 µg/mL for Meloxicam and 5–30 µg/mL for Rizatriptan. The method proved to be sensitive, specific, and suitable for routine quality control of these drugs in pharmaceutical formulations.
Keywords: Keywords: High-Performance Liquid Chromatography, Meloxicam, Rizatriptan, Anti-inflammatory drugs, pharmaceutical formulation, Method validation.
Cite Article: "Formulation Method Development And Validation Of Active Pharmaceutical Ingredient in Tablet Dosage Form", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.10, Issue 6, page no.b733-b740, June-2025, Available :http://www.ijrti.org/papers/IJRTI2506188.pdf
Downloads: 000539
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2506188
Registration ID:204990
Published In: Volume 10 Issue 6, June-2025
DOI (Digital Object Identifier):
Page No: b733-b740
Country: Nagpur , Maharashtra , India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2506188
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2506188
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner